![David Berman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Berman
Corporate Officer/Principal bij
MODERNA, INC.
Vermogen: 212 799 $ op 31-08-2026
Profiel
David Berman is Chief Development Officer at Moderna, Inc. since 2026.
Formerly, Dr. Berman was Executive VP & Head-Research & Development at Immunocore Holdings Plc from 2019 to 2026, Head-Immuno Oncology Franchise at AstraZeneca PLC from 2017 to 2018, Head-Early Stage Oncology Program at MedImmune LLC from 2015 to 2017, and Head-Immuno Oncology at Bristol Myers Squibb Co. from 2005 to 2015.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from The University of Texas Southwestern Medical Center.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-04-2026 | 5.859 ( 0,01% ) | 212 799 $ | 31-08-2026 |
Actieve functies van David Berman
| Bedrijven | Functie | Begin |
|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | 02-03-2026 |
Eerdere bekende functies van David Berman
| Bedrijven | Functie | Einde |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Hoofd Techniek/Wetenschap/O&O | 27-02-2026 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01-01-2018 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | 01-01-2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-2015 |
Opleiding van David Berman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
86
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moderna, Inc.
 Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
